The data highlighted a decreased risk of GIST associated with a six bp deletion in the thymidylate synthase (TS) gene (formerly rs34489327, delTInsTTAAAG), and a reduced TTP associated with the wild-type allele in the reduced folate carrier (RFC) [23]. This evidence concerns the gene TYMS and gastrointestinal stromal tumor.